Related Experiment Video
Updated: Jun 22, 2026

07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
External validation of a claims-based algorithm for classifying kidney-cancer surgeries.
David C Miller1, Christopher S Saigal, Joan L Warren
1Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA. dcmiller@umich.edu
BMC Health Services Research
|June 9, 2009
Summary
Medicare claims accurately identify surgical treatments for early-stage kidney cancer. This validation confirms their reliability for population-based studies on cancer surgery patterns.
Area of Science:
- Oncology
- Health Services Research
- Medical Informatics
Background:
- Limited literature exists on the accuracy of medical claims data for identifying surgical treatments in kidney cancer patients.
- Previous studies have not validated Medicare claims data for classifying surgical procedures in this population.
- This study addresses the need for reliable data sources to understand surgical care patterns in early-stage kidney cancer.
Purpose of the Study:
- To externally validate a Medicare claims-based algorithm for classifying surgical treatments in early-stage kidney cancer patients.
- To compare the accuracy of Medicare claims data against SEER registry data and clinical operative reports.
- To assess the reliability of claims data for identifying specific surgical procedures like partial and radical nephrectomy.
Main Methods:
- Utilized linked SEER-Medicare data for 6,515 patients with early-stage kidney cancer.
- Calculated agreement between Medicare claims and SEER data for cancer-directed surgery identification.
- Validated the claims algorithm against medical records for a subset of 120 cases, determining sensitivity, specificity, and predictive values.
Main Results:
- High agreement (93%, kappa=0.69) observed between Medicare claims and SEER data for identifying cancer-directed surgery.
- Excellent agreement (97%, kappa=0.83) for classifying partial versus radical nephrectomy.
- Claims algorithm demonstrated over 90% positive predictive value for partial nephrectomy and laparoscopic surgery identification when compared to clinical operative reports.
Conclusions:
- Medicare claims data are a reliable and accurate source for population-based studies on surgical care patterns in early-stage kidney cancer.
- The validated algorithm enhances the utility of claims data for epidemiological research in renal cell carcinoma.
- Findings support the use of Medicare claims for monitoring surgical trends and outcomes in kidney cancer patients.